Source:http://linkedlifedata.com/resource/pubmed/id/14683494
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2003-12-19
|
pubmed:abstractText |
High-throughput technologies allow the selection of new biological targets for drug discovery in the post-genomic era. These tools increase the need of new methods to rapidly obtain potent small molecules and natural products to discover new lead structures. In particular, the solid-phase synthesis offers a great potential to obtain large compound sets.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1386-2073
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
673-91
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2003
|
pubmed:articleTitle |
Natural product-like and other biologically active heterocyclic libraries using solid-phase techniques in the post-genomic era.
|
pubmed:affiliation |
Kekulé-Institut für Organische Chemie und Biochemie der Rheinischen, Friedrich-Wilhelms-Universität Bonn, Gerhard-Domagk-Strasse 1, D-53121 Bonn, Germany.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|